CIK: 0001542339 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 12, 2025
Total Value ($000): $307,121 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDXG | MIMEDX GROUP INC | 28,195,249 | $196,803 | 64.1% | $7.32 | -5.1% | COM | 602496101 |
| BVS | BIOVENTUS INC | 13,021,324 | $87,113 | 28.4% | $13.37 | -48.1% | COM CL A | 09075A108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 1,084,857 | $15,448 | 5.0% | $4.68 | +145.9% | COM NEW | 30233G209 |
| TELA | TELA BIO INC | 4,110,709 | $6,125 | 2.0% | $11.82 | -85.1% | COM | 872381108 |
| MNOV | MEDICINOVA INC | 1,105,941 | $1,405 | 0.5% | $2.95 | -56.2% | COM NEW | 58468P206 |
| VERO | VENUS CONCEPT INC | 99,021 | $228 | 0.1% | $3.59 | -32.0% | COM | 92332W303 |